The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback